$111.65 0%
DXCM Stock Price vs. AI Score
Data gathered: July 23

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Dexcom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

Price $111.65
Target Price Sign up
Volume 1,690,000
Market Cap $44.4B
Year Range $102.11 - $140.45
Dividend Yield 0%
PE Ratio 72.5
Earnings Date July 25 '24
Industry Medical Devices

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24916M678M562M146M190M0.320
Q4 '231.03B696M657M256M261M0.500
Q3 '23970M638M623M121M247M0.500
Q2 '23865M624M546M116M167M0.340
Q1 '23737M575M463M49M71M0.170

Insider Transactions View All

Brown Michael Jon filed to sell 66,901 shares at $114.3.
June 28 '24
FOLETTA MARK G filed to sell 56,398 shares at $117.2.
June 20 '24
FOLETTA MARK G filed to sell 56,697 shares at $116.7.
June 20 '24
FOLETTA MARK G filed to sell 62,391 shares at $115.2.
June 20 '24
FOLETTA MARK G filed to sell 59,704 shares at $117.8.
June 20 '24

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Nov 8, 23 Buy $1K - $15K
Rohit Khanna
Nov 8, 23 Buy $1K - $15K
Rohit Khanna
Nov 8, 23 Sell $1K - $15K

What is the Market Cap of Dexcom?

The Market Cap of Dexcom is $44.4B.

What is Dexcom's PE Ratio?

As of today, Dexcom's PE (Price to Earnings) ratio is 72.5.

When does Dexcom report earnings?

Dexcom will report its next earnings on July 25 '24.

What is the current stock price of Dexcom?

Currently, the price of one share of Dexcom stock is $111.65.

How can I analyze the DXCM stock price chart for investment decisions?

The DXCM stock price chart above provides a comprehensive visual representation of Dexcom's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Dexcom shares. Our platform offers an up-to-date DXCM stock price chart, along with technical data analysis and alternative data insights.

Does DXCM offer dividends to its shareholders?

As of our latest update, Dexcom (DXCM) does not offer dividends to its shareholders. Investors interested in Dexcom should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Dexcom?

Some of the similar stocks of Dexcom are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.